Caption Management’s Ascendis Pharma A/S ASND Stock Holding History

Caption Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,499	Closed	-$1.21M	–	1658
2025 Q2	$1.12M	Sell	6,499 -19,501	-75%	-$3.18M	0.01%	902
2025 Q1	$4.05M	Sell	26,000 -19,381	-43%	-$2.77M	0.04%	461
2024 Q4	$6.25M	Buy	+45,381	New	+$5.97M	0.06%	306
2024 Q3	–	Sell	-4,600	Closed	-$621K	–	1263
2024 Q2	$627K	Sell	4,600 -4,826	-51%	-$657K	0.01%	767
2024 Q1	$1.42M	Buy	+9,426	New	+$1.35M	0.02%	644
2022 Q4	–	Sell	-24,472	Closed	-$2.84M	–	1275
2022 Q3	$2.53M	Buy	+24,472	New	+$2.32M	0.03%	557
2022 Q2	–	Sell	-3,701	Closed	-$435K	–	1436
2022 Q1	$435K	Sell	3,701 -1,899	-34%	-$220K	0.01%	1163
2021 Q4	$753K	Buy	+5,600	New	+$833K	0.01%	1145
2021 Q2	–	Sell	-4,400	Closed	-$586K	–	1284
2021 Q1	$567K	Buy	+4,400	New	+$669K	0.01%	785
2019 Q4	–	Sell	-45,979	Closed	-$5.11M	–	818
2019 Q3	$4.43M	Buy	+45,979	New	+$5.13M	0.23%	117

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Caption Management's ASND Position: Q3 2025 in Review

Caption Management sold out of Ascendis Pharma A/S (ASND) in Q3 2025, closing a stake of 6,499 shares — an estimated $1.21M sold.

Caption Management first reported a position in ASND in Q3 2019 and held it in 10 quarters. The position peaked at $6.25M in Q4 2024. 279 funds tracked by Wall St. Rank hold ASND as of Q3 2025.

Caption Management reported no remaining Ascendis Pharma A/S position as of Q3 2025 after selling out during the quarter.
Caption Management sold 6,499 Ascendis Pharma A/S shares in Q3 2025, an estimated $1.21M.
Caption Management first reported a position in Ascendis Pharma A/S in Q3 2019 and held it in 10 quarters.
Caption Management's Ascendis Pharma A/S position peaked at $6.25M in Q4 2024.
279 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2025.

Based on Caption Management's 13F filing for Q3 2025, filed 14 Nov 2025.